MedDay Announces Full Enrollment for MD1003 Phase III

Biotin is an emerging therapy for the treatment of secondary progressive MS.
Post Reply
User avatar
ton
Family Member
Posts: 76
Joined: Thu May 27, 2010 2:00 pm

MedDay Announces Full Enrollment for MD1003 Phase III

Post by ton » Fri Nov 09, 2018 11:14 am


Post Reply
  • Similar Topics
    Replies
    Views
    Last post